News & Updates
Showing Multidisciplinary articles
Showing
Show Multimedia Only

Pre-TURBT mitomycin-C improves RFS in NMIBC
22 hours ago
byAudrey Abella
In the updated 5-year analysis of a randomized phase II trial, administering two doses of intravesical mitomycin-C (MMC) immediately before transurethral resection of bladder tumour (TURBT) improves recurrence-free survival (RFS) in individuals with non-muscle invasive bladder cancer (NMIBC).
Pre-TURBT mitomycin-C improves RFS in NMIBC
22 hours ago
Albuminuria an important fracture risk predictor in T2D
a day ago
byChristina Lau
Albuminuria is an important and independent predictor of hip fractures and major osteoporotic fractures (MOF) in patients with type 2 diabetes (T2D), and the presence of additional metabolic syndrome (MetS)–related traits compounds this fracture risk, particularly in nonobese patients, a population-based retrospective cohort study in Hong Kong has shown.







